Advanced kidney cancer
Showing 9976 - 10000 of >10,000
Urine mtDNA and Beta 2-MG to Predict Acute Kidney Injury for
Recruiting
- Surgery-Complications
- +2 more
-
Wonju, Gangwon, Korea, Republic ofWonju Severance Christian Hospital
Aug 9, 2022
Malignant Gastric Outlet Obstruction Trial (EUS-guided gastroenterostomy (EUS-GE), Laparoscopic gastroenterostomy (LGE))
Not yet recruiting
- Malignant Gastric Outlet Obstruction
- EUS-guided gastroenterostomy (EUS-GE)
- Laparoscopic gastroenterostomy (LGE)
- (no location specified)
Sep 29, 2022
Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15
Completed
- Adult T-Cell Lymphoma/Leukemia
- +2 more
- Recombinant human Interleukin-15 (rhIL-15)
- Mogamulizumab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 9, 2022
POLECAT: Perioperative Delta Renin Concentration
Not yet recruiting
- Post Operative Vasoplegic Syndrome
- Acute Kidney Injury
- (no location specified)
Jul 4, 2023
SCCHN, Squamous Cell Carcinoma Trial in Birmingham (Cisplatin)
Recruiting
- SCCHN
- Squamous Cell Carcinoma
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Jan 5, 2023
Gastric Cancer Trial (Pre-rehabilitation, Standard medical care)
Not yet recruiting
- Gastric Cancer
- Pre-rehabilitation
- Standard medical care
- (no location specified)
Jul 24, 2022
Advanced Solid Tumors, NSCLC Trial in Durham (AMG 479, Everolimus, Panitumumab)
Completed
- Advanced Solid Tumors, Non-small Cell Lung Cancer
- AMG 479, Everolimus, Panitumumab
-
Durham, North CarolinaDuke University Medical Center
Aug 26, 2019
Patients With NSCLC Treated With Nivolumab Under the ATU Program
Completed
- Non-small Cell Lung Cancer
- +2 more
-
Aix-En-Provence, France
- +71 more
Jun 29, 2022
Index Colonoscopy to Predict Polyp Recurrence During
Completed
- Colon Polyp
- (no location specified)
Oct 3, 2022
NSCLC Trial in Guangzhou (Osimertinib, Savolitinib)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
-
Guangzhou, Guangdong, ChinaGuangdong Lung Cancer Institute, Guangdong General Hospital, Gua
Dec 6, 2021
Proenkephalin A and Kidney Replacement Therapy
Suspended
- Acute Kidney Injury
- None planned
-
Gießen, Hessen, GermanyUniversity Hospital Gießen and Marburg
Jan 23, 2023
Urinary Tract Infections, Transplant-Related Disorder Trial in Tehran (Phage)
Recruiting
- Urinary Tract Infections
- Transplant-Related Disorder
- Phage
-
Tehran, Iran, Islamic Republic ofNooshin Dalili
Jul 21, 2023
Osteoarthritis, Osteoarthritis, Hip Trial (0.9%sodium chloride, 95% ethanol)
Not yet recruiting
- Osteoarthritis
- Osteoarthritis, Hip
- 0.9%sodium chloride
- 95% ethanol
- (no location specified)
Oct 11, 2023
Acute Kidney Injury, Cardiac Disease, Surgery Trial in Nanjing (Erythropoietin, 0.9% sodium chloride, cardiac surgery)
Terminated
- Acute Kidney Injury
- +2 more
- Erythropoietin
- +2 more
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Jan 8, 2023
Malignant Tumor Trial in Ann Arbor, Columbus (ponatinib HCl, laboratory biomarker analysis)
Unknown status
- Malignant Neoplasm
- ponatinib hydrochloride
- laboratory biomarker analysis
-
Ann Arbor, Michigan
- +1 more
Feb 14, 2020
Overweight or Obesity Trial in Ho Chi Minh (Auricular acupuncture, Thread embedding acupuncture, Sham Thread embedding
Recruiting
- Overweight or Obesity
- Auricular acupuncture
- +2 more
-
Ho Chi Minh, VietnamUniversity of Medical Center HCMC - Branch no.3
Oct 18, 2023
Cutaneous Squamous Cell Carcinoma Trial in Amsterdam (Nivolumab, Ipilimumab)
Recruiting
- Cutaneous Squamous Cell Carcinoma
-
Amsterdam, Noord Holland, NetherlandsNKI-AVL
Oct 24, 2022
Diabetic Retinopathy, Vitreomacular Traction Trial in Minya (Methotrexate 25 MG/ML, parsplana vitrectomy)
Recruiting
- Diabetic Retinopathy
- Vitreomacular Traction
- Methotrexate 25 MG/ML
- parsplana vitrectomy
-
Minya, Minia, Egyptophthalmology department, Minia university hospital
Sep 8, 2023
NSCLC Trial in Guangzhou (PLB1001)
Recruiting
- Non-small Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaGuangdong General Hospital
Feb 5, 2020
Advanced Solid Tumor Trial in Wuxi (Oncolytic Virus Injection (RT-01))
Recruiting
- Advanced Solid Tumor
- Oncolytic Virus Injection (RT-01)
-
Wuxi, Jiangsu, ChinaWuxi People's Hospital
Jan 19, 2022
Metronomic Oral Vinorelbine in Elderly Locally Advanced /
Unknown status
- Locally Advanced/ Metastatic NSCLC
-
Pesaro, Yes, ItalyAzienda Ospedaliera Ospedali Riuniti Marche Nord
Dec 23, 2019
Therapeutic Drug Use for CKD Patients
Active, not recruiting
- Chronic Kidney Disease
- angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
-
Jinan, Shandong, ChinaXiao Li,MD
Apr 18, 2023